Delivery Order SPE2DB22D1017-SPE2DB25FG3MJ
Award Date
5/27/25
Potential Completion Date
5/28/25
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the pharmaceutical product YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, with a ceiling value of $1,296.92 and a completion date of November 14, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product, with a ceiling value of $3,330.74 and an ultimate completion date of May 22, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,389.28, is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a medical product, with a period of performance through June 13, 2024. The contract has a firm fixed price pricing type and is not associated with any set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,358.18, is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of June 24, 2024. This award is not associated with a set-aside designation. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,614.31 firm fixed-price contract is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a medical product, with a completion date of January 9, 2024. The contract was not designated under any set-aside program. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,916.98, is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a specialty medication. The award has a ceiling value of $4,112.90 and a performance period ending on March 15, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a respiratory medication. The contract has a ceiling value of $5,075.84 and runs until September 18, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous federal...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,224.99, is a delivery order for the drug YUPELRI 175 MCG/3 ML SOLUTION UD 3ML. The contract has an ultimate completion date of April 9, 2025 and utilizes a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award, valued at $1,273.79, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the pharmaceutical product YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, with a period of performance through January 9, 2025. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation. In addition to this Delivery Order, Amerisourcebergen holds a $999,999,999 Indefinite Delivery...